Kelley A. Fedler, BS

Surveillance Manager
Element
North Liberty, Iowa, United States

Disclosure(s): Paratek Pharmaceuticals: Grant/Research Support

Presentation(s):

• 318 - Activity of Omadacycline Against 35,000 Bacterial Clinical Isolates and Resistant Organism Subsets from Patients in the United States (2019–2023)

  Friday, October 18, 2024
  12:25 PM – 12:30 PM US PT